Every health AI model is a decision engine — and an attack surface. The Risks (with Evidence) Why Healthcare Is Special Framework for Defence Aligned with the EU AI Act’s high-risk obligations: risk management, logging, human oversight (European Commission). In healthcare, AI isn’t “just software” — it’s safety-critical infrastructure.
Your pacemaker is now an endpoint. Attackers read release notes too. Why Devices + AI Are Tricky Case in Point The 2017 firmware recall for ~465k Abbott (St. Jude) pacemakers shows the stakes, a patch was issued to mitigate RF cybersecurity vulnerabilities (Read more). Regulatory Overlap Secure Design Patterns Ship devices with a patch plan,…
Pharma wants real-world data; adversaries want it more. Case Studies Risk Hotspots Mitigations Your real-world data strategy is only as strong as your real-world security.
VCs love TAM slides. Users love not being breached. Why Startups Under-Secure Investors Waking Up Diligence Questions Minimal Security Stack Secure runway beats growth at any cost, especially in health.
Europe wrote the rules. Now it has to monetise them. The EU Stack Why It Can Be a Moat Risks & Tensions If Europe aligns security, standards, and procurement, trust becomes a market advantage — not a compliance tax.
Is AI safe to use in healthcare? AI can improve diagnostics, treatment recommendations, and patient monitoring but without safeguards it can be manipulated. Adversarial attacks on medical imaging AI have been shown to cause misclassifications (European Journal of Radiology). The EU recognises this: under the AI Act, most health AI is “high-risk” and must meet…
AI in healthcare is often sold as a story of improved diagnostics, personalised therapies, and predictive medicine. But beneath that dream lies a fragile backbone: security. One breach, one exploited model, and reputations, finances, even lives are at stake. In Europe, this tension is amplified. The Artificial Intelligence Act entered into force on 1 August…
Chronic care raises capital, CE-marks keep flowing, leadership benches shift, and new data reveals just how underfunded CEE’s healthtech sector remains. I am travelling, so this brief will be, well, brief. People on the move Venous Stent B.V. — Darren Spencer appointed CEO to drive its iliac venous stent programme into first-in-human trials and through…
Workflow AI meets hard regs: funding into clinical workforce & pathology AI, a CEE mental health roll-up, and CE marks in resuscitation, MSK and neuro-mobility. People on the move Haughton Design (UK) appoints Dr. Ash Ghadar as CEO to scale medtech/drug-delivery design services; a reminder that device commercialisation chops are in demand. Allianz Partners (FR)…
Europe’s Quantum Moment Europe is not just a consumer of quantum technologies, it’s investing heavily to become a global leader. The Quantum Technologies Flagship commits €1 billion over 10 years to research and commercial pilots. Add Horizon Europe and EuroHPC’s hybrid supercomputers, and you get a uniquely European playbook: strong public co-funding, national champions, and…